Our firm has deep experience with a range of cases involving harmful pharmaceuticals and faulty medical devices. Here, we outline some of the specific drugs and devices that have been the focus of litigation.

Hormone Replacement Therapies like AndroGel
These therapies have been associated with serious cardiovascular events and other severe health issues, leading to significant legal action against manufacturers.

• Overview of Androgel Testosterone Risks

Androgel, a leading testosterone replacement therapy, has come under significant scrutiny due to its association with an increased risk of serious health issues, including heart attacks and strokes. Despite being approved only for the treatment of hypogonadism (a medically documented deficiency in natural serum testosterone), Androgel has been heavily marketed by AbbVie for a broader range of symptoms collectively referred to as “Low-T.” These symptoms encompass age-related declines in energy and libido, which the marketing claims can be effectively treated with testosterone. However, studies have shown that many users of testosterone supplements may not have been tested for hypogonadism, raising concerns about the justification for their use.

• Legal and Medical Concerns

In 2013, studies revealed that men using Androgel or other testosterone drugs might face a two- to three-fold increased risk of heart attacks and strokes. Following these findings, the FDA issued a warning on January 31, 2014, advising both doctors and patients to carefully weigh the risks associated with testosterone therapies like Androgel. The aggressive marketing campaigns suggesting broader benefits of testosterone therapy, without sufficient medical justification and adequate warnings about potential risks, have led to allegations of misleading advertising and understatement of dangers by AbbVie.

Acid Reflux Medications
(Nexium/Prilosec/Prevacid)

Long-term use of these proton pump inhibitors has been linked to kidney disease, fractures, and other severe health issues, sparking widespread litigation.

Overview of Proton Pump Inhibitors and Associated Risks

Nexium, Prilosec, and Prevacid, widely recognized brands of proton pump inhibitors (PPIs), are used to treat acid reflux and heartburn by reducing stomach acid production. Originally available by prescription and later as over-the-counter remedies, these drugs have become among the most commonly used medications globally. However, a significant long-term medical study involving over 10,000 patients has revealed that prolonged use of these PPIs may increase the risk of Chronic Kidney Disease (CKD) by 50%, with some users facing up to three times the risk of Acute Kidney Injury.

Legal and Medical Concerns

Published by the Journal of the American Medical Association, a rigorous 13-year study analyzed the health outcomes of 15,792 individuals, eventually focusing on 10,482 patients after excluding those with incomplete medical records. This comprehensive research found a substantial increase in the risk of developing chronic kidney disease—a condition characterized by the gradual loss of kidney function, which is measured through the glomerular filtration rate. Chronic kidney disease severely affects life expectancy, particularly without interventions like dialysis, which many patients find diminishes their quality of life.

Cancer Treatment Drugs like Taxotere

Patients have experienced permanent hair loss, significantly impacting their quality of life and leading to lawsuits against manufacturers for not warning about this side effect.

Overview of Taxotere and Permanent Hair Loss
Taxotere, a chemotherapy drug developed by Sanofi, is widely used in cancer treatment and is known to cause temporary hair loss, a common side effect of chemotherapy. However, a significant number of patients have experienced permanent hair loss after using Taxotere, a side effect not adequately disclosed to patients in the United States. This permanent condition has profound emotional and psychological effects, leading to distress and a negative body image.

Legal and Medical Concerns
Despite being aware since 2005 that about 9% of Taxotere users suffered permanent hair loss, Sanofi did not inform American patients of this risk. Information about these risks was shared with the medical community and the public in Canada and Europe but was withheld in the U.S. This omission came even as Sanofi conducted a study starting in 1996, the year Taxotere was approved, which eventually confirmed the risk of permanent hair loss.

Further compounding the issue, allegations of fraudulent marketing practices have emerged, including illegal kickbacks and incentives offered to physicians for prescribing Taxotere for off-label uses—practices that pharmaceutical companies explicitly prohibit. These actions have led to numerous lawsuits, including claims from a former Sanofi official who has accused the company of unethical business practices.

Common and Serious Side Effects of Xeljanz

While some patients experience minor side effects such as respiratory infections or high blood pressure,
others face life-threatening conditions including:

• Heart attacks and heart failure
• Strokes and other cardiovascular events
• Blood clots and embolisms
• Cancer and liver damage

Elmiron: widely prescribed for interstitial cystitis (IC)

Overview of Elmiron and Its Risks
Elmiron, widely prescribed for interstitial cystitis (IC), has been linked to severe eye conditions such as maculopathy and retinal damage, which can significantly impact patients’ health and quality of life. Recent studies have highlighted the risks associated with long-term Elmiron use, raising concerns about the drug’s safety.

Legal and Medical Concerns
Despite the growing evidence of serious side effects, Janssen Pharmaceuticals, the maker of Elmiron, did not adequately warn patients about the potential for permanent vision damage. Dr. Brad Bradshaw’s Law Firm is committed to holding them accountable and supporting those who have been affected.

Symptoms of Maculopathy and Retinal Damage

Patients using Elmiron have reported various symptoms indicating serious eye conditions:

Maculopathy Symptoms:

• Visual disturbances like blurred vision and difficulty seeing details
• Dark or blind spots in central vision, impacting daily activities
• Loss of visual acuity, particularly in central vision
• Metamorphopsia, where straight lines appear wavy or bent

Retinal Damage Symptoms:

• Visual distortions, including blurred and distorted vision
• Loss of peripheral vision or development of blind spots
• Photopsia, or seeing flashing lights and floating spots
• Decreased clarity and sharpness of vision

Treatment Options

While the damage caused by Elmiron might be irreversible, there are ways to manage the conditions:

• Ophthalmologist Evaluations: Comprehensive eye exams are crucial for diagnosing and assessing the extent of eye damage.
• Regular Monitoring: Continuous monitoring can help track the progression of the condition and adjust treatments accordingly.
• Medications and Injections: These may be prescribed to manage symptoms or address underlying issues like abnormal blood vessel growth.
• Low Vision Aids: Tools such as magnifiers and specialized glasses can help those with significant vision loss manage their daily activities.

Tasigna cancer medication

Overview of Tasigna and Associated Risks

Tasigna (nilotinib), a widely used cancer medication, has been linked to severe vascular conditions, notably atherosclerosis—a dangerous narrowing of the veins that can lead to tissue death, limb amputation, coronary artery disease, and even death. Despite evidence emerging as early as 2011, the American public has not been adequately warned about these risks by Novartis, the Swiss pharmaceutical company producing Tasigna.

Legal and Medical Concerns

Approved by the FDA in 2010, Tasigna has been a top-selling cancer treatment, generating significant revenue for Novartis. However, the company’s history has been marred by legal issues, including a $390 million settlement in 2013 to resolve a case involving illegal kickbacks and misbranding related to Tasigna. While Novartis issued warnings about vascular side effects in Canada in 2013, such disclosures were not extended to the American medical community or patients.

Ozempic: weight loss drug

Overview of Ozempic and Its Medical Use

Ozempic, a brand name for the drug semaglutide, is widely used for weight management and to treat type 2 diabetes. Marketed as a solution to combat obesity and improve well-being, Ozempic promises significant benefits for those struggling with weight issues. However, despite its popularity and effectiveness, Ozempic users may face undisclosed risks that could lead to serious health complications.

Legal and Medical Concerns

While the manufacturer, Novo Nordisk, initially warned of potential thyroid cancer risks, they failed to provide adequate warnings about the possibility of severe gallbladder problems associated with the drug. This lack of transparency has left many patients vulnerable to unexpected and serious health issues.

Gallbladder Complications Linked to Ozempic

Recent studies have shown a troubling link between Ozempic use and gallbladder diseases, including cholelithiasis (gallstones) and cholecystitis (inflammation of the gallbladder). These conditions not only cause significant pain and discomfort but can also lead to more severe health risks if not treated promptly.

Cholelithiasis (Gallstones):

• Description: Gallstones are hard deposits of digestive fluid that can form in the gallbladder.
• Symptoms: These include intense abdominal pain, pain between shoulder blades, nausea, and vomiting.

Cholecystitis (Gallbladder Inflammation):

• Description: This inflammation is often caused by gallstones blocking the bile duct, leading to bile accumulation and gallbladder irritation.
• Symptoms: Severe abdominal pain, pain radiating to the back or right shoulder, fever, and nausea are common symptoms.

Opioid Addiction in Infants

Opioid-related birth injuries continue to necessitate vigilant legal oversight

Overview of the Opioid Crisis on Newborns

The opioid crisis has tragically affected the most vulnerable among us, including newborns. Babies exposed to opioids while in utero often suffer from Neonatal Abstinence Syndrome (NAS), experiencing severe withdrawal symptoms after birth. This condition highlights a devastating aspect of the opioid epidemic—infants born dependent on opioids due to maternal exposure.

Legal and Medical Concerns

Understanding Neonatal Abstinence Syndrome (NAS)

NAS occurs when a fetus is exposed to drugs, such as opioids, during pregnancy. After birth, affected newborns may experience a range of withdrawal symptoms, including:

• High-pitched, persistent crying
• Tremors
• Vomiting
• Diarrhea
• Seizures

These symptoms can last for several months, and the long-term consequences often include developmental delays and growth issues, necessitating ongoing medical and therapeutic interventions.

Research indicates that many pharmaceutical companies were aware of the risks associated with opioid use, including the potential for addiction and dependency in newborns, yet continued to promote these drugs as safe for long-term use. This misleading information has led to increased prescriptions and widespread misuse, exacerbating the crisis.

Medical Devices such as CPAP Machines, Hernia Mesh, Essure Birth Control, and IVC Filters. These devices have had recalls or warnings due to severe complications ranging from infections to device migration and organ perforation.

• Overview of Philips CPAP Device Recall

Philips, a leading Dutch medical equipment manufacturer, is conducting a major recall of millions of its CPAP, Bi-Level PAP, and mechanical ventilator devices. This recall was initiated due to concerns that a foam component used in these devices for noise reduction could degrade and become toxic, potentially leading to cancer and other serious health issues.

Health Risks Associated with Foam Degradation

The polyurethane foam in question may break down and release particles that could cause:

• Skin, eye, and respiratory tract irritation
• Chest pressure and cough
• Headache and sinus infection
• Inflammatory responses and asthma
• Potential toxic effects on organs, including risks of liver and kidney failure
• Increased risk of cancers, such as lung cancer

Philips’ Response and Legal Implications

Despite receiving reports related to foam degradation, Philips did not initially inform the public or medical community in the United States about these potential risks. It was not until significant complaints arose that Philips issued a recall, affecting approximately 3-4 million devices globally. This has led to a growing number of lawsuits from users who have experienced adverse health effects, claiming that Philips failed to adequately warn users of the risks.

In-depth Medical Analysis
 Our collaboration with medical experts helps to establish a clear link between the use of specific drugs or devices and the injuries incurred, forming the backbone of our legal strategy.

Personalized Legal Representation
 We provide customized legal strategies designed to meet the individual needs of each client, acknowledging the unique aspects of each case.

Aggressive Advocacy
 We are committed to holding pharmaceutical giants and medical device manufacturers accountable, using thorough research and vigorous legal tactics to ensure justice for our clients.

Comprehensive Legal Support for Victims

Case Evaluation
We begin with a comprehensive assessment, evaluating every aspect of your case to advise on the best course of action.

Medical-Legal Expertise
By combining our legal acumen with in-depth medical knowledge, we offer our clients a significant advantage in complex injury cases.

Contingency Fee Basis
We alleviate financial pressure during your recovery by offering our services on a no-win, no-fee basis.

Seek Justice with Confidence

With a record of substantial settlements and verdicts, like the $100 million in talcum powder litigation, Dr. Brad Bradshaw’s Law Firm is a formidable ally in the fight against negligent pharmaceutical companies and device manufacturers. Our dedication to justice, combined with unparalleled legal and medical expertise, lights the path for those seeking accountability.